For prescribing information, click here

This section of the website is for UK service managers or commissioners only. If you are not a service manager or commissioner, please click here

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.

Resources

Adult Spasticity

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) therapeutic indications

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) is indicated for symptomatic treatment of focal spasticity of:

  • Upper limbs in adults
  • Lower limbs in adults affecting the ankle joint

Please click here to see the full therapeutic indications.

Talking Head Videos

A practical guide to implementing a flexible PIFU model
A practical guide to implementing a flexible PIFU model
Video 23:54

How the implementation of a Patient-Initiatied Follow-Up (PIFU) model may be a practical solution to capacity challenges and help achieve efficiency savings within BoNT-A services.

DYS-UK-008737 | November 2024
Making sense of the changing NHS and funding flows
Making sense of the changing NHS and funding flows
Video 12:15

Judy Willits discusses how the NHS payment scheme has evolved and what the changes could mean for your botulinum toxin services.

DYS-UK-008947 | November 2024

Contact your Ipsen representative

Send request
Resources